Literature DB >> 19198135

[End of life care for patients with ALS in Japan].

Mieko Ogino1.   

Abstract

Because the whole of the management of ALS is palliative care, in this paper I presented about the management of each symptom, respiratory care, decision making of the mechanical ventilation, and the end of life care in Japan. We must be aware that the patients with ALS can continue to live if they decide to wear the tracheostomy ventilation (TV) even just before death, it is completely different form situation in cancer patients. In Japan about 20% of ALS patients choose TV, this figure is much higher than western countries. On the other hand, only 14% of neurologist have experience of opioids usage for ALS in 2007, much lower than western countries. We started to use opioids for ALS patients in 2005. We use morphine 10-30 mg/day as maintenance dose in early phase without sever side effect. Eighty-eight percent patients reported relief of breathlessness, in 4 patients out of 9, PCO2 was decreased. It is big problem that the health insurance does not cover the cost of opioids for ALS. I want to emphasize that the best effort should be taken to relieve suffering not only for cancer patient but for every patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19198135     DOI: 10.5692/clinicalneurol.48.973

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  3 in total

1.  Analysing the influencing factors on caregivers' burden among amyotrophic lateral sclerosis patients in China: a cross-sectional study based on data mining.

Authors:  Ling Lian; Minying Zheng; Ruojie He; Jianing Lin; Weineng Chen; Zhong Pei; Xiaoli Yao
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

2.  Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan.

Authors:  Charles Tzu-Chi Lee; Yi-Wen Chiu; Kai-Chen Wang; Chi-Shin Hwang; Kuan-Hsiang Lin; I-Ta Lee; Ching-Piao Tsai
Journal:  J Epidemiol       Date:  2012-10-27       Impact factor: 3.211

3.  Retrospective longitudinal study of ALS in Cyprus: Clinical characteristics, management and survival.

Authors:  Christiana A Demetriou; Petros M Hadjivasiliou; Kleopas A Kleopa; Yiolanda P Christou; Eleni Leonidou; Theodoros Kyriakides; Eleni Zamba-Papanicolaou
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.